CRISPR Therapeutics reinforces its Team with Top Executives from Pfizer and McKinsey
A new strategic movement in the hot CRISPR field: CRISPR Therapeutics ramps up its leadership…
12/08/2015 - 2 minutes
CRISPR: A Promising Industry With Many Questions Unanswered
The gene-editing tool CRISPR-Cas9 has taken over the life sciences world since its development in 2012. CRISPR has changed the way biology research is done, simplifying and speeding up the study of diseases and the discovery of drugs, as well as having a huge impact on crop and food development. Among all its possible applications, the fact that CRISPR can be used to tweak the human genome has made it especially promising for previously difficult-to-treat diseases.
But how does CRISPR work? What kind of therapies are being developed? How is the genome-editing market evolving? And how are stakeholders navigating the complex intellectual property around this technology? Find out the answers to these questions and more on this page.
Show More
The Genome Editing Toolbox: ZFNS, TALENS, and CRISPR in Biomedicine
This report covers the industry’s most common genome-editing tools, like CRISPR-Cas9, provides exclusive insights by experts, looks at the market, and addresses future applications and challenges of genome-editing tools.
Go to ReportLatest CRISPR Articles
Here are 7 Biotech Stories you Must Read During the Holidays
The Holidays are a perfect time to enjoy the sun and relax peacefully on the…
06/08/2015 - 3 minutes
How Servier saved Cellectis, the French CAR-T Miracle
Cellectis, the €1bn CAR-T company, just announced it reached a significant milestone in its collaboration…
15/07/2015 - 5 minutes
Meet Eligo, the Startup which Raised €2M to Redefine Antibiotics using CRISPR
Antibiotic resistance is a public health problem worldwide. According to WHO, by 2050, over 10 million…
09/07/2015 - 6 minutes
French collaboration to develop Oncology-targeted Therapy
PEP-Therapy and CleveXel Pharma will co-develop targeted therapy in oncology. The product is based on…
10/06/2015 - 2 minutes
CRISPR technology receives the Spanish ‘Nobel prize’
CRISPR continues to amass prizes and to consolidate itself as the biggest discovery of the…
01/06/2015 - 2 minutes
CRISPR-armed Viruses to kill Antibiotic-Resistant Bacteria
Antibiotics abuse is creating a whole new generation of antibiotic-resistant bacteria. As the tolerance to…
26/05/2015 - 2 minutes
Gene-editing Technology war continues while CRISPR Therapeutics raised €79.5M
As the CRISPR-Cas9 war still goes on, CRISPR Therapeutics closed a Series A and B…
30/04/2015 - 2 minutes
Desktop Genetics launches a new Gene Editing Platform
Desktop Genetics has just launched the DeskGen Platform for gene editing. It combines elements of the…
25/04/2015 - 2 minutes
CRISPR Therapeutics opens Boston R&D Office to Win the CRISPR War
CRISPR Therapeutics appointed Bill Lundberg to Chief Scientific Officer to lead the company’s development programs…
08/04/2015 - 2 minutes
Gene editing to make French fries less unhealthy
A promising biotechnological approach or an innovative way of avoiding regulation? Large companies spend an…
06/04/2015 - 4 minutes
Live from Bio-Europe 2015: The product development challenges in the gene therapy field
Gene Therapy is really the hot topic right now in the field of Biotech especially with…
10/03/2015 - 3 minutes
